Ovarian tissue cryopreservation: An update

Ovarian Tissue Cryopreservation: An Alternative Option

In 2010, there were an estimated 730,000 new cancer cases in females, resulting in approximately 270,000 deaths [ 1 ] . Although malignancy remains a critical health concern, signi fi cant medical advances in cancer detection and treatment have improved survival rates for patients. Gonadotoxic chemotherapy or radiation for malignant disease may result in altered ovarian function, affecting both...

Ovarian tissue and oocyte cryopreservation

There are relatively few effective clinical options for preserving female fertility, particularly following aggressive chemotherapy and/or radiotherapy treatment protocols. This document reviews the scientific background, current technology, clinical results and potential future applications of two methods for preserving female fertility—ovarian tissue cryopreservation and oocyte cryopreservati...

An Update on Ovarian Aging and Ovarian Reserve Tests

Ovaries are the female organs that age more quickly than other tissues such as the uterus, the pituitary gland or pancreas. Different from males, an interesting question is why and how the females lose fertility so rapidly. During the aging process, both the number and quality of the oocytes in the ovaries decrease and reach to a point beyond that no more viable offspring may be produced and th...

Ovarian tissue cryopreservation: a committee opinion.

Ovarian tissue cryopreservation is an option to preserve reproductive potential in patients who must urgently undergo aggressive chemotherapy and/or radiotherapy or who have other medical conditions requiring treatment that may threaten ovarian function and subsequent fertility. Ovarian tissue cryopreservation may be the only option available to prepubertal girls undergoing such treatments. How...

Human Ovarian Tissue Cryopreservation as Fertility Reserve